Texas Court Rejects J&J’s Bankruptcy Attempt to End Talc Suits
A bankruptcy court in Texas rejected J&J’s proposed bankruptcy plan to settle claims related to its talc lawsuits for the ...
GlobalData on MSN9h
FDA awards ODD status to Sanofi’s rilzabrutinib for two rare conditions
Sanofi's oral, reversible Bruton’s tyrosine kinase (BTK) inhibitor rilzabrutinib has gained US Food and Drug Administration ...
Zacks Investment Research on MSN4h
Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure
This week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of ...
Morningstar22h
Sanofi SA ADR SNY
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Pharmaceutical Technology18h
Protected: Digital cognitive assessments and blood-based biomarkers in Alzheimer’s research
More than 70% of dementia diagnoses are for Alzheimers’s. Credit: via Shutterstock.